MA41529A1 - Obeticholic acid compositions and methods of use - Google Patents

Obeticholic acid compositions and methods of use

Info

Publication number
MA41529A1
MA41529A1 MA41529A MA41529A MA41529A1 MA 41529 A1 MA41529 A1 MA 41529A1 MA 41529 A MA41529 A MA 41529A MA 41529 A MA41529 A MA 41529A MA 41529 A1 MA41529 A1 MA 41529A1
Authority
MA
Morocco
Prior art keywords
methods
acid compositions
obeticholic acid
obturate
dissolution
Prior art date
Application number
MA41529A
Other languages
French (fr)
Inventor
Richard G Lancaster
Kay K Olmstead
Masashi Kagihiro
Ikuko Taoka
Mitsuhiro Matono
Mark Pruzanski
David Shapiro
Roya Hooshmand-Rad
Richard Pencek
Cathi Sciacca
Lise Eliot
Jeffrey Edwards
Leigh A Macconell
Tonya K Marmon
Original Assignee
Intercept Pharmaceuticals Inc
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc, Sumitomo Dainippon Pharma Co Ltd filed Critical Intercept Pharmaceuticals Inc
Priority claimed from PCT/US2016/029369 external-priority patent/WO2016176208A1/en
Publication of MA41529A1 publication Critical patent/MA41529A1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne des formulations d'acide obéticholique à stabilité, dissolution, et/ou solubilité améliorée(s), des procédés de préparation de celles-ci pour utilisation et des procédés de traitement de diverses maladies et états.The present invention provides improved stability, dissolution, and / or solubility acidic obturate acid formulations, methods for their preparation for use and methods of treating various diseases and conditions.

MA41529A 2015-04-27 2016-04-26 Obeticholic acid compositions and methods of use MA41529A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562153040P 2015-04-27 2015-04-27
PCT/US2016/029369 WO2016176208A1 (en) 2015-04-27 2016-04-26 Compositions of obeticholic acid and methods of use

Publications (1)

Publication Number Publication Date
MA41529A1 true MA41529A1 (en) 2018-07-31

Family

ID=59485562

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41529A MA41529A1 (en) 2015-04-27 2016-04-26 Obeticholic acid compositions and methods of use

Country Status (2)

Country Link
AR (1) AR104427A1 (en)
MA (1) MA41529A1 (en)

Also Published As

Publication number Publication date
AR104427A1 (en) 2017-07-19

Similar Documents

Publication Publication Date Title
MA40755B1 (en) Compositions comprising bacterial strains
MA40754B1 (en) Compositions comprising bacterial strains
MA41013A (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MA43335A (en) TRANSTHYRETINE (TTR) RNA COMPOSITIONS AND METHODS FOR USING THEM FOR THE TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH TTR
MA41060A (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
EA201792047A1 (en) NEW CONNECTIONS
MA43094B1 (en) Maytansinoid derivatives, their conjugates, and methods of use
MA42376B1 (en) Substituted oxopyridine derivatives
MA55434A (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
MD3442972T2 (en) Bromodomain inhibitors
MA41010A (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
MA43763A (en) PRE-FUSION RSV PROTEIN F SOLUBLE AND STABILIZED FOR USE IN THE PROPHYLAXIS OF RSV INFECTION
FR3028753B1 (en) AQUEOUS OR HYDRO-ALCOHOLIC GEL OF SYNTHETIC PHYLLOSILICATES AS A VISCOSING AGENT, MATIFIING AND / OR HOMOGENIZING APPLICATION
MX2019003805A (en) Activators of autophagic flux and phospholipase d and clearance of protein aggregates including tau and treatment of proteinopathies.
MA41977B1 (en) Imidazopyrazinones used as pde1 inhibitors
EA201591541A1 (en) BETA SECRETASE INHIBITORS 1 (BACE 1)
MA40875A (en) 2,4-DIAMINO-QUINOLEIN SUBSTITUTED AS NEW ANTI-CANCER AGENTS
MA38349A1 (en) Estra-1,3,5 (10), 16-tetraeno-3-carboxamide to inhibit 17-beta-hydroxysteroid dehydrogenase (akr1c3)
MA38925A1 (en) Substituted phenylalanine derivatives
BR112022000855A2 (en) nlrp3 modulators
EA201890460A1 (en) COMPOSITIONS AND METHODS OF TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISORDERS
MA32224B1 (en) (Pyrazolyl-carbonyl) imidazolidinone derivatives for the treatment of retroviral diseases
PH12018502703A1 (en) An oxazine derivative for use in the prevention of alzheimer's disease in at risk patients
MA41529A1 (en) Obeticholic acid compositions and methods of use
MA39533A1 (en) Compounds, pharmaceutical composition and their use in the treatment of neurodegenerative diseases